Scholars@Duke

Zoledronate, fractures, and mortality after hip fracture.

Publication ,  Journal Article
Karam, R; Al-Khalidi, H; Steinbuch, M
Published in: N Engl J Med
February 28, 2008
Link to item

Duke Scholars

Hussein Rashid Al-Khalidi
Author Hussein Rashid Al-Khalidi Biostatistics & Bioinformatics, Division of Biostatistics

Published In

N Engl J Med

EISSN

1533-4406

Publication Date

February 28, 2008

Volume

358

Issue

9

Start / End Page

969

Location

United States

Related Subject Headings

  • Zoledronic Acid
  • Research Design
  • Imidazoles
  • Humans
  • Hip Fractures
  • General & Internal Medicine
  • Fractures, Bone
  • Diphosphonates
  • Data Interpretation, Statistical
  • Bone Density Conservation Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Karam, R., Al-Khalidi, H., & Steinbuch, M. (2008). Zoledronate, fractures, and mortality after hip fracture. N Engl J Med, 358(9), 969.
Karam, Roger, Hussein Al-Khalidi, and Michael Steinbuch. “Zoledronate, fractures, and mortality after hip fracture.” N Engl J Med 358, no. 9 (February 28, 2008): 969.
Karam R, Al-Khalidi H, Steinbuch M. Zoledronate, fractures, and mortality after hip fracture. N Engl J Med. 2008 Feb 28;358(9):969.
Karam, Roger, et al. “Zoledronate, fractures, and mortality after hip fracture.” N Engl J Med, vol. 358, no. 9, Feb. 2008, p. 969.
Karam R, Al-Khalidi H, Steinbuch M. Zoledronate, fractures, and mortality after hip fracture. N Engl J Med. 2008 Feb 28;358(9):969.

Published In

N Engl J Med

EISSN

1533-4406

Publication Date

February 28, 2008

Volume

358

Issue

9

Start / End Page

969

Location

United States

Related Subject Headings

  • Zoledronic Acid
  • Research Design
  • Imidazoles
  • Humans
  • Hip Fractures
  • General & Internal Medicine
  • Fractures, Bone
  • Diphosphonates
  • Data Interpretation, Statistical
  • Bone Density Conservation Agents